Recombinant Human TRPA1 Protein，His

Transient receptor potential ankyrin 1 (TRPA1) is a non-selective cation channel that plays a critical role in sensory perception, particularly in response to noxious stimuli including temperature, pain, and inflammatory signals. TRPA1 is predominantly expressed in primary sensory neurons and is activated by a variety of endogenous and exogenous chemicals, making it a key player in nociception and the body's response to harmful stimuli. The study of TRPA1 recombinant proteins has gained significant attention in recent years, driven by its potential implications in pain management and the development of therapeutics for conditions such as chronic pain and neuroinflammatory disorders. Research has focused on characterizing the structural and functional properties of TRPA1, which can be challenging due to its complex biophysical characteristics and post-translational modifications. By producing recombinant TRPA1 in heterologous systems, researchers aim to gain insights into its activation mechanisms, ion conduction properties, and interaction with various ligands. Understanding these aspects is crucial for elucidating TRPA1's role in pathophysiological conditions and for the rational design of novel analgesics targeting this channel. This research not only enhances our basic knowledge of ion channels but also paves the way for the development of new interventions for pain-related disorders, highlighting TRPA1 as a promising target in pharmacology and therapeutic development.